Kailera Therapeutics, Inc.
KLRA
19 insider filings · Latest: Jul 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Apr 22 8:15 PM | RTW INVESTMENTS, LP10% Owner | Purchase | 500,000 | $16.00 | $8.0M | 10,776,820(I) | View → |
| Apr 20, 2026 | Apr 20 10:10 PM | BAIN CAPITAL INVESTORS LLC10% Owner | Purchase | 8,398,438 | $16.00 | $134.4M | 26,255,581(I) | View → |
| Apr 20, 2026 | Apr 20 10:08 PM | Adam KoppelDirector, 10% Owner | Purchase | 1,562,500 | $16.00 | $25.0M | 22,583,268(I) | View → |
| Apr 20, 2026 | Apr 20 10:01 PM | Bain Capital Life Sciences Investors, LLC10% Owner | Purchase | 1,562,500 | $16.00 | $25.0M | 22,583,268(I) | View → |
| Apr 20, 2026 | Apr 20 10:00 PM | Andrew T. KaplanDirector, 10% Owner | Purchase | 8,398,438 | $16.00 | $134.4M | 26,255,581(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 20 9:01 PM | Douglas W. PaganChief Financial Officer | Grant/Award | 200,000 | $16.00 | 100,000(D) | View → |
← Previous
Page 2 of 2